Letter: Balancing Cost and Consequence of Colon Capsule Endoscopy in Colorectal Cancer Pathways—Finding the Sweet Spot. Authors' Reply

IF 6.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Alimentary Pharmacology & Therapeutics Pub Date : 2025-03-27 DOI:10.1111/apt.70105
James Turvill, Monica Haritakis, Scott Pygall, Emily Bryant, Harriet Cox, Greg Forshaw, Crispin Musicha, Victoria Allgar, Robert Logan, Mark McAlindon
{"title":"Letter: Balancing Cost and Consequence of Colon Capsule Endoscopy in Colorectal Cancer Pathways—Finding the Sweet Spot. Authors' Reply","authors":"James Turvill,&nbsp;Monica Haritakis,&nbsp;Scott Pygall,&nbsp;Emily Bryant,&nbsp;Harriet Cox,&nbsp;Greg Forshaw,&nbsp;Crispin Musicha,&nbsp;Victoria Allgar,&nbsp;Robert Logan,&nbsp;Mark McAlindon","doi":"10.1111/apt.70105","DOIUrl":null,"url":null,"abstract":"<p>The authors of the large English colon capsule endoscopy (CCE) diagnostic accuracy study are grateful to Dr. Lei et al. for their informed and thoughtful observations [<span>1, 2</span>]. We think that there are two important and related observations of our own to make in response.</p><p>First, on an ‘intention to investigate’ basis, rather than in complete and adequately prepared CCE, more polyps were detected by CCE than colonoscopy. This meant that an informed management plan could be made for many patients even when CCE was incomplete or inadequately prepared. Second, as you infer, CCE was introduced to mitigate the impact of the Covid-19 pandemic on colorectal cancer diagnosis. That is, its purpose was primarily to inform risk rather than prevent onward investigation, as one might plan for in the future.</p><p>We very much agree that multiple, mitigatable factors, not yet fully defined, may contribute to the onward investigation rate and so inform how best CCE should complement a future colorectal diagnostics pathway. Beyond patient selection, touched on above, all of the factors outlined are absolutely pertinent. Our own view about polyp overdiagnosis is uncertain. Double counting seems unlikely since polyp detection was recorded on both a per patient and per polyp basis. The high false positivity of polyps ≥ 10 mm in those who had matched investigations, both of which were complete and adequately prepared, suggests that the reference standard may need to be revisited.</p><p>We believe other factors are also important, such as shared decision making, patient choice, and the purpose of CCE in a clinical setting. We very much agree that such should help generate a ‘balanced approach’ for future recommendations. Our study importantly allows us to move beyond the safety and accuracy across a broad clinical setting and into that exciting new space where we can optimise.</p><p><b>James Turvill:</b> conceptualization, writing – original draft. <b>Monica Haritakis:</b> project administration. <b>Scott Pygall:</b> funding acquisition. <b>Emily Bryant:</b> funding acquisition. <b>Harriet Cox:</b> project administration. <b>Greg Forshaw:</b> project administration. <b>Crispin Musicha:</b> formal analysis. <b>Victoria Allgar:</b> formal analysis. <b>Robert Logan:</b> conceptualization, funding acquisition, writing – original draft. <b>Mark McAlindon:</b> conceptualization, writing – original draft.</p><p>This article is linked to Turvill et al. paper. To view this article, visit, https://doi/10.1111/apt.70046 and https://doi.org/10.1111/apt.70104.</p>","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":"61 9","pages":"1583-1584"},"PeriodicalIF":6.7000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.70105","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/apt.70105","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The authors of the large English colon capsule endoscopy (CCE) diagnostic accuracy study are grateful to Dr. Lei et al. for their informed and thoughtful observations [1, 2]. We think that there are two important and related observations of our own to make in response.

First, on an ‘intention to investigate’ basis, rather than in complete and adequately prepared CCE, more polyps were detected by CCE than colonoscopy. This meant that an informed management plan could be made for many patients even when CCE was incomplete or inadequately prepared. Second, as you infer, CCE was introduced to mitigate the impact of the Covid-19 pandemic on colorectal cancer diagnosis. That is, its purpose was primarily to inform risk rather than prevent onward investigation, as one might plan for in the future.

We very much agree that multiple, mitigatable factors, not yet fully defined, may contribute to the onward investigation rate and so inform how best CCE should complement a future colorectal diagnostics pathway. Beyond patient selection, touched on above, all of the factors outlined are absolutely pertinent. Our own view about polyp overdiagnosis is uncertain. Double counting seems unlikely since polyp detection was recorded on both a per patient and per polyp basis. The high false positivity of polyps ≥ 10 mm in those who had matched investigations, both of which were complete and adequately prepared, suggests that the reference standard may need to be revisited.

We believe other factors are also important, such as shared decision making, patient choice, and the purpose of CCE in a clinical setting. We very much agree that such should help generate a ‘balanced approach’ for future recommendations. Our study importantly allows us to move beyond the safety and accuracy across a broad clinical setting and into that exciting new space where we can optimise.

James Turvill: conceptualization, writing – original draft. Monica Haritakis: project administration. Scott Pygall: funding acquisition. Emily Bryant: funding acquisition. Harriet Cox: project administration. Greg Forshaw: project administration. Crispin Musicha: formal analysis. Victoria Allgar: formal analysis. Robert Logan: conceptualization, funding acquisition, writing – original draft. Mark McAlindon: conceptualization, writing – original draft.

This article is linked to Turvill et al. paper. To view this article, visit, https://doi/10.1111/apt.70046 and https://doi.org/10.1111/apt.70104.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
信:结肠胶囊内窥镜在结直肠癌途径中的成本和结果的平衡——找到最佳点。作者的回复
大英式结肠胶囊内窥镜(CCE)诊断准确性研究的作者感谢Lei博士等人的见多识广和深思熟虑的观察[1,2]。我们认为,我们自己有两个重要的和相关的观察要作回应。首先,在“意向调查”的基础上,而不是在完整和充分准备的CCE中,CCE比结肠镜检查发现更多的息肉。这意味着即使在CCE不完整或准备不足的情况下,也可以为许多患者制定知情的管理计划。第二,正如你所推断的,引入CCE是为了减轻新冠肺炎疫情对结直肠癌诊断的影响。也就是说,它的目的主要是通知风险,而不是防止进一步的调查,就像人们将来可能计划的那样。我们非常同意,尚未完全确定的多种可缓解因素可能有助于进一步的调查率,因此告知CCE应如何最好地补充未来的结直肠诊断途径。除了上面提到的患者选择之外,所有列出的因素都是绝对相关的。我们对息肉过度诊断的看法是不确定的。重复计算似乎不太可能,因为息肉检测记录在每个病人和每个息肉的基础上。在那些进行了完整和充分准备的匹配调查的患者中,息肉≥10 mm的高假阳性表明可能需要重新审视参考标准。我们认为其他因素也很重要,如共同决策、患者选择和CCE在临床环境中的目的。我们非常同意,这将有助于为今后的建议产生一种“平衡的方法”。重要的是,我们的研究使我们能够在广泛的临床环境中超越安全性和准确性,进入我们可以优化的令人兴奋的新领域。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
15.60
自引率
7.90%
发文量
527
审稿时长
3-6 weeks
期刊介绍: Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.
期刊最新文献
Editorial: Dysfunctional Neutrophils in Cirrhosis With Acute Decompensation-Why It Matters. Authors' Reply. Editorial: Dysfunctional Neutrophils in Cirrhosis With Acute Decompensation: Why It Matters. Editorial: Decoding Gut Failure in Cirrhosis-Villin-1 and the Emergence of a Seventh Organ Failure. Authors' Reply. Editorial: Decoding Gut Failure in Cirrhosis: Villin-1 and the Emergence of a Seventh Organ Failure. Review Article: Renal Safety Profiles of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, and Entecavir for the Treatment of Chronic Hepatitis B Infection-General and Special Populations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1